空气中的颗粒物污染对慢性阻塞性肺病 (COPD) 细胞和分子机制的影响
Hudson C Taylor-Blair1, Alexander Chi Wang Siu2, Adam Haysom-McDowell3
1School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW 2007, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia.
The Science of the total environment
|September 25, 2024
概括
吸入空气污染颗粒物 (PM) 会导致慢性肺炎,氧化应激和细胞损伤,导致慢性阻塞性肺病 (COPD). 了解这些机制对于开发新的COPD疗法和减少空气污染至关重要.
科学领域:
- 环境健康 环境健康
- 肺部病理学 肺部病理学
- 毒理学 毒理学 毒理学
背景情况:
- 空气污染中的颗粒物 (PM) 与慢性呼吸道疾病 (如COPD) 有关.
- 慢性肺炎是全球主要的健康问题,治疗选择有限,医疗费用高.
研究的目的:
- 阐明导致慢性颗粒物暴露后慢性慢性肺炎发展的细胞和分子机制.
- 突出PM诱导的COPD中病理生理路径的相互联系.
主要方法:
- 对PM吸入及其对肺组织影响的现有文献的综述.
- 细胞和分子通路的分析,包括炎症,氧化应激和呼吸道重塑.
主要成果:
- 吸入PM会通过NF-κB等途径触发慢性肺炎,从而增加促炎细胞因子.
- 暴露于PM会导致持续的氧化应激和肺膜破坏,导致细胞衰老.
- 微粒诱导呼吸道重塑,增加亲纤维细胞因子和原沉积,这是慢性肺炎的特征.
结论:
- 长期暴露于PM会引发一连串导致COPD的炎症和氧化事件.
- 了解这些机制为COPD提供了潜在的治疗点.
- 对空气污染采取紧急行动是必要的,以减轻其严重的呼吸系统健康影响.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
COPD: Pathogenesis and Clinical Features
243
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
243
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


